• Clinical-endocrinological and echografical aspects of good-quality dysplasia of mammary glands at women of reproductive age
en To content

Clinical-endocrinological and echografical aspects of good-quality dysplasia of mammary glands at women of reproductive age

HEALTH OF WOMAN. 2019.8(144): 75–77; doi 10.15574/HW.2019.144.75
S.E. Gladenko, A.A. Dovgan
Shupyk National Medical Academy of Postgraduate Education of MH of Ukraine, Kiev

The objective: to study modern clinical-endocrinologic and echografical aspects of good-quality dysplasia of mammary glands at women of reproductive age.

Materials and methods. Were surveyed 90 patients aged from 22 till 45 years which are divided into 3 groups on 30 women: 1 group – group of control – the woman without pathology in mammary glands. The 2nd group included patients with diffuse form of good-quality dysplasia of mammary glands. The 3rd group was made by patients with a nodal form of a good-quality dysplasia of mammary glands. The complex the researches included clinical, echografical, endocrinologic and statistical methods.

Results. Results of the conducted researches testify that it is possible to refer existence of chronic extragenital diseases, smoking, an early menarche to risk factors of development of a good-quality dysplasia of mammary glands, disturbances of a menstrual cycle, hysteromyoma and an adenomyosis, an artificial or spontaneous abortion. Disturbance of ratio of LG/FSG is characteristic for all patients with diseases of mammary glands. For these patients as the hypoprogesteronemia is characteristic. Disturbance of ratio of levels of Gonadotropinums in combination with hypoprogesteronomia can be referred to risk factors of development of good-quality dysplasia of mammary glands.

Conclusion. The received results needs to be considered when developing algorithm of diagnostic and treatment-and-prophylactic actions.

Key words: good-quality dysplasia of mammary glands, clinic, endocrinology, echography.

REFERENCES

1. Shurpiak SO, Pyrohova VI. 2018. Reproduktyvne zdorovia i komorbidni stany. Aspekty diahnostyky, likuvannia i reabilitatsii. Lviv, Prostir-M: 224.

2. Hammad AE. 2016. Women and health security. Wld Hlth Statist. Quart. 49(2):74-7.

3. Volff M fon, Shtute P. 2017. Ginekologicheskaya endokrinologiya i reproduktivnaya meditsina, per. s nem. pod red. EN Andreevoy. M, MEDpress-inform: 512.

4. Radzinskiy VE. 2011. Reproduktivnoe zdorove: Ucheb. posobie. M, RUDN: 727.

5. Zaporozhan VM ta in. 2013. Akusherstvo ta ginekologiia: u 4-kh t.: natsionalnyi pidruchnyk. K, VSV Medytsyna: 1032.

6. Kornatska AH, Tatarchuk TF, Dubenko OD. 2017. Bezplidnist ta dobroiakisni zakhvoriuvannia molochnoi zalozy. Kyiv: 271.

7. Babaeva NA, Ashrafyan LA, Antonova IB, Aleshikova OI, Ivashina SV. 2017. Rol gormonalnyih narusheniy v kantserogeneze opuholey zhenskoy reproduktivnoy sistemy. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie 1:76-82.